Oak Thistle LLC Takes $321,000 Position in Bath & Body Works, Inc. (NYSE:BBWI)

Oak Thistle LLC bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 8,269 shares of the company's stock, valued at approximately $321,000.

Several other hedge funds and other institutional investors have also modified their holdings of BBWI. True Wealth Design LLC grew its stake in shares of Bath & Body Works by 5,270.0% during the third quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock valued at $34,000 after purchasing an additional 1,054 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt lifted its holdings in Bath & Body Works by 300.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company's stock worth $38,000 after buying an additional 900 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new position in Bath & Body Works in the 3rd quarter valued at $39,000. TD Private Client Wealth LLC increased its stake in shares of Bath & Body Works by 24.2% in the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company's stock valued at $54,000 after buying an additional 331 shares during the period. Finally, Meeder Asset Management Inc. raised its position in shares of Bath & Body Works by 480.3% during the third quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company's stock worth $55,000 after acquiring an additional 1,436 shares during the last quarter. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Stock Performance

BBWI stock traded up $0.10 during mid-day trading on Friday, hitting $36.78. 3,152,026 shares of the company were exchanged, compared to its average volume of 2,919,820. The firm has a market cap of $7.97 billion, a P/E ratio of 8.97, a P/E/G ratio of 0.98 and a beta of 1.82. Bath & Body Works, Inc. has a 1-year low of $26.20 and a 1-year high of $52.99. The firm's 50 day simple moving average is $36.30 and its 200 day simple moving average is $33.68.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping analysts' consensus estimates of $0.46 by $0.03. The business had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm's quarterly revenue was up 3.1% on a year-over-year basis. During the same period last year, the business posted $0.48 earnings per share. On average, equities research analysts predict that Bath & Body Works, Inc. will post 3.26 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were issued a dividend of $0.20 per share. The ex-dividend date was Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.18%. Bath & Body Works's payout ratio is presently 19.51%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on BBWI shares. Wells Fargo & Company upgraded Bath & Body Works from an "equal weight" rating to an "overweight" rating and raised their price target for the company from $42.00 to $48.00 in a report on Friday, January 10th. JPMorgan Chase & Co. raised their target price on shares of Bath & Body Works from $35.00 to $39.00 and gave the company a "neutral" rating in a research note on Tuesday, November 26th. Telsey Advisory Group reissued an "outperform" rating and set a $42.00 price target on shares of Bath & Body Works in a research note on Monday, November 25th. TD Cowen raised their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a "buy" rating in a research note on Thursday, December 12th. Finally, Argus reiterated a "hold" rating on shares of Bath & Body Works in a research report on Friday, January 10th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $43.06.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.